Home / Business / Novo’s Wegovy Pill to Test Demand From Consumers With Cash

Novo’s Wegovy Pill to Test Demand From Consumers With Cash

US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.

LONDON, Dec 23 (Reuters) – Novo Nordisk’s newly approved weight-loss pill version of Wegovy will ‌be ​a test case for the fast-growing cash-paying consumer ‌market, with plans for the first highly effective oral treatment to go straight to U.S. self-… [3565 chars]

Source: U.S. News & World Report | Published: 2025-12-23T06:06:00Z

Credit: U.S. News & World Report

Tagged:

Leave a Reply

Your email address will not be published. Required fields are marked *